![]() |
|
|
Vol. 285, Issue 1, 223-227, April 1998
Departments of Pharmaceutical Sciences (K.-I.H., Y.H., V.H.L.L.), Ophthalmology (V.H.L.L.), Medicine (K.-J.K.), Physiology and Biophysics (K.-J.K.), and Biomedical Engineering (K.-J.K.) and Will Rogers Institute Pulmonary Research Center (K.-J.K.), Schools of Pharmacy, Medicine, and Engineering, University of Southern California, Los Angeles, California
| |
Abstract |
|---|
|
|
|---|
In this study, the transport mechanism of NG-nitro-L-arginine (L-NA), a nitric oxide synthase inhibitor that may be useful for alleviating intraocular inflammation, was characterized in the pigmented rabbit conjunctiva. L-NA, when applied to the mucosal side of the conjunctiva, led to dose-dependent increases in the short-circuit current (Isc) at 37°C but not at 4°C or under the Na+-free condition. Serosally added 1 mM L-NA did not elicit any change in the Isc. Mucosally added 1 mM L-NA elicited a net absorptive Na+ flux of 0.09 µEq/(cm2·hr), comparable with the Isc change. L-NA transport at 0.1 mM in the mucosal-to-serosal (ms) direction was 22 times greater than that in the serosal-to-mucosal direction. There was a good correlation between the ms flux of L-NA and the Isc changes elicited by L-NA under the same experimental conditions. L-NA transport was saturable, with a Km of 0.35 mM and a maximal flux of 290 pmol/(cm2·min). Hill analysis of L-NA flux observed at 0.1 mM L-NA in response to varying Na+ concentrations in the mucosal bathing fluid yielded a Hill coefficient of 0.98, suggesting a 1:1 coupling between Na+ and L-NA. Moreover, ms 3H-L-NA transport was inhibited by basic amino acids (L-Arg and L-Lys) and a neutral amino acid (L-Leu), but not by an acidic amino acid (L-Glu) and the D-stereoisomer of L-NA. In the case of L-Arg, inhibition was competitive with a Ki of 0.034 mM. Taken together, the above findings are consistent with the involvement of the L-Arg transport system B0,+ in the conjunctival transport of L-NA.
| |
Introduction |
|---|
|
|
|---|
NO
is the oxidation product of one of the guanidino nitrogens of L-Arg as
a result of catalysis mediated by the two different forms of NOS:
constitutive NOS and iNOS (Moncada et al., 1991
). iNOS is
expressed only on stimulation with endotoxin or combinations of
inflammatory cytokines, including interferon-
, tumor necrosis factor-
and interleukin-1 (Goureau et al., 1994
;
Liversidge et al., 1994
; Zidek and Frankova, 1995
). In the
eye, NO plays a cytostatic or cytotoxic role in the conjunctiva (Meijer
et al., 1996
), the retinal pigmented epithelium (Goureau
et al., 1994
; Liversidge et al., 1994
) and the
anterior uveal tract (Mandai et al., 1994
) during
inflammation.
Recently, an endogenous NOS inhibitor,
NG,NG-dimethyl-L-arginine,
has been found to exist at 0.2 to 0.5 µM in the bovine ciliary muscle
to regulate NO synthesis (Azuma et al., 1997
). In addition to N-iminoethyl-L-ornithine and
NG-amino-L-arginine (Moncada et
al., 1991
), NOS inhibitors such as L-NA, L-NAME and L-MMA have
been reported to lower NO production in human (Goureau et
al., 1994
) and rat (Liversidge et al., 1994
) retinal
pigmented epithelial cells and the rat anterior uveal tract (Mandai
et al., 1994
). Thus, Goureau et al. (1994)
reported that cytokine-induced nitrite formation in cultured human
retinal pigmented epithelial cells was reduced by 84%, 88% and 78%
in the presence of 0.1 mM L-NA, L-NAME and L-MMA, respectively. Mandai et al. (1994)
also observed that L-NA administered
intraperitoneally (20 mg/rat) inhibited iNOS activity by 80% in
endotoxin-induced uveitis. However, there has been no report on the
topical ocular delivery of NOS inhibitors for possible treatment of
intraocular inflammatory conditions. Given its juxtaposition to the
uveal tract, the conjunctiva may offer an attractive pathway for
topically applied NOS inhibitors to gain intraocular access (Ahmed and
Patton, 1987
).
In a previous study (Hosoya et al., 1997
), we provided
evidence for the involvement of system B0,+, a
Na+-dependent transporter of neutral and basic
amino acids (Winkle et al., 1990
), in the transport of L-Arg
in the pigmented rabbit conjunctiva. We also showed that the NOS
inhibitors L-NA, L-NAME and L-MMA inhibited L-Arg transport to varying
degrees. The purpose of the present study was to determine whether
system B0,+ was indeed involved in the
conjunctival transport of NOS inhibitors. L-NA, one of the more potent
NOS inhibitors (Moncada et al., 1991
; Goureau et
al., 1994
), was chosen as a model compound because it was the only
NOS inhibitors commercially available in radiolabeled form.
| |
Materials and Methods |
|---|
|
|
|---|
Animals. Male Dutch-belted pigmented rabbits, weighing 2.5 to 3.0 kg, were purchased from American Rabbitry (Los Angeles, CA). The investigations using rabbits described in this report conformed to the Guiding Principles on the Care and Use of Animals (DHEW Publication, NIH 80-23).
Chemicals. L-NA, L-Lys, L-Glu, L-Leu and ouabain were obtained from Sigma Chemical (St. Louis, MO). D-NA was obtained from Research Biochemicals (Natick, MA). NG-Nitro-L-[2,3,4,5-3H]arginine HCl (3H-L-NA; specific activity, 57 Ci/mmol) and 22NaCl (666 mCi/mg Na+) were purchased from Amersham (Downers Grove, IL).
Buffer solutions. Unless otherwise indicated, all experiments were conducted in bicarbonated Ringer's solution maintained at 37°C and pH 7.4 under 95% air/5% CO2. Bicarbonated Ringer's solution contained 111.5 mM NaCl, 4.8 mM KCl, 29.2 mM NaHCO3, 0.75 mM NaH2PO4, 1.04 mM CaCl2·2H2O, 0.74 mM MgCl2·6H2O and 5 mM D-glucose. Na+-free Ringer's solution was prepared by equimolar replacement of NaCl, NaH2PO4 and NaHCO3 with choline chloride, KH2PO4 and choline bicarbonate, respectively. Ringer's solutions containing 8.8, 17.6, 35.3, 52.9, 70.5 and 105.8 mM Na+ were prepared by mixing appropriate proportions of Na+-free Ringer's solution with normal Ringer's solution.
Tissue preparation.
We previously reported detailed methods
for preparing the excised pigmented rabbit conjunctiva for Ussing
chamber studies (Kompella et al., 1993
). Briefly, rabbits
were killed with an injection of 85 mg/kg sodium pentobarbital solution
into a marginal ear vein. The entire eyeball was removed from the
orbit, taking care not to damage the conjunctival epithelium. Within 15 min of surgery, the excised conjunctiva was mounted onto a tissue adapter with a circular aperture of 1.0 cm2. The
adapter-tissue assembly was then placed in a modified Ussing chamber
maintained at 36 ± 1°C by a circulating water bath. The bathing
solution of the tissue was bubbled with 5% CO2
and 95% air to maintain the pH at 7.4 and to provide adequate
agitation of the solution.
Measurement of bioelectric parameters.
All experiments were
performed under short-circuit condition with the use of an automatic
voltage-clamp device (558C-5; Bioengineering Department, University of
Iowa, Iowa city, IA). The potential difference (PD) was measured with
two matched calomel electrodes. Two polyethylene (PE 90) bridges
(containing 4% agar in 3 M KCl), whose tips were located near the
center of tissue surfaces, were used to connect the reservoir fluid
electrically to the electrode wells. The electrical output of matched
calomel electrodes was amplified by the voltage-clamp unit. Direct
current flowing across the tissue was measured with a pair of matched
Ag/AgCl electrodes with conducting agar bridges, whose tips were
positioned away from the tissue surfaces at the far ends of two
reservoirs. The Isc flowing in the
bath-tissue-bath circuit was monitored and recorded on one channel of a
strip-chart recorder (Kipp and Zonen, Delft, Netherlands). At 60-sec
intervals, a 2-mV voltage pulse (V) was imposed for 3 sec across the
short-circuited tissue to estimate the TEER as a surface area
normalized ratio of applied pulse voltage to observed deflection in
resultant current (I) flowing on top of Isc,
TEER = (V/I)A, where A is the nominal surface area of the Ussing
chamber opening (1 cm2). Before each experiment,
the solution resistance (<100
·cm2) was
compensated for by the automatic voltage-clamp unit (Kompella et
al., 1993
). The PD, Isc and TEER of the
conjunctiva were monitored continually. The baseline PD was 15.4 ± 0.4 mV (tear-side negative), the Isc was
12.5 ± 0.3 µA/cm2 and the TEER was
1283 ± 37
·cm2 (n = 173). These values were comparable to those reported previously (Kompella et al., 1993
; Hosoya et al., 1997
).
Measurement of L-NA and Na+ fluxes. Unidirectional L-NA or Na+ fluxes across the conjunctiva were determined separately using 3H-L-NA or 22Na, respectively, at 1 µCi/ml. Then, 500-µl samples were collected from the receiver side at 0.5, 1.0, 1.5, 2.0 and 3.0 hr for assay of radioactivity in a liquid scintillation counter (LS 1801; Beckman, Fullerton, CA). The Isc and TEER were monitored periodically to ascertain tissue viability and integrity.
Data analysis. Unidirectional fluxes (J) for L-NA and Na+ were estimated from the steady-state rate of radioactivity appearance in the receiver fluid. The Papp of L-NA was estimated from the steady-state slope of a plot showing cumulative amount of radioactivity vs. time according to the equation: Papp = (dQ/dt)/(A·C0), where dQ/dt is the steady-state transport rate (mol/sec), A is the nominal surface area of the Ussing chamber opening and C0 is the initial radioactivity concentration (mol/ml) in the donor fluid.
The kinetic parameters for L-NA transport processes in the conjunctiva were estimated by fitting the transport data to the following equation using the software program NFIT (Island Products, Galveston, TX) for nonlinear least-square regression analysis:
|
| |
Results |
|---|
|
|
|---|
L-NA transport characteristics.
L-NA, when applied to the
mucosal side of the conjunctiva at 37°C, increased the
Isc, as shown in figure
1. The increase in Isc (
Isc) was 0.15 ± 0.04 µA/cm2 at 0.02 mM, increasing to
1.73 ± 0.1 µA/cm2 at 1 mM L-NA.
Lineweaver-Burk plot of
Isc vs.
[L-NA] yielded an apparent Km value
of 0.21 mM L-NA and a maximal
Isc
(
Iscmax) value of 1.68 µA/cm2 (r2 = .99). By
contrast, no Isc change was observed with
serosally added L-NA (1 mM) or mucosally added L-NA (0.02-1 mM) at
4°C (data not shown).
|
30 min (fig.
2). As shown in table
1, the Papp for 0.1 mM L-NA in the sm direction was 22 times lower than that in the ms
direction (P < .05). Na+-free condition or
lowering temperature to 4°C significantly decreased the ms L-NA
Papp by 95% and 97%, respectively (P < .05). In addition, the presence of 0.5 mM ouabain in the serosal
bathing solution reduced ms L-NA transport by 86%. Concurrently, the
Isc was completely abolished, compared with no
change in either the TEER or the ms Papp of 10 µM 14C-D-mannitol, a paracellular
marker (0.35 ± 0.04 × 10
6 cm/sec in
the absence of ouabain vs. 0.27 ± 0.11 × 10
6 cm/sec in the presence of ouabain) (Hosoya
et al., 1997
|
|
6 cm/sec) (r2 = 0.9).
At 4°C, L-NA flux increased linearly with concentration (fig. 3).
|
Stoichiometry of Na+-coupled L-NA transport. 3H-L-NA flux also saturated with Na+ concentration, reaching a value of 19.1 ± 0.1 pmol/(cm2·min) at 17.6 mM and 59.4 ± 5.7 pmol/(cm2·min) at 141 mM (fig. 4). The Km value was 58.3 mM for Na+ and the Jmax value was 86.2 pmol/(cm2·min) according to Lineweaver-Burk analysis. Hill analysis yielded a coupling ratio of 0.98 (r2 = 0.97), suggesting 1:1 coupling between Na+ and L-NA.
|
Inhibition of Na+-coupled L-NA transport by select amino acids. The basic amino acids, L-Arg and L-Lys, and the neutral amino acid, L-Leu, significantly reduced ms L-NA transport (P < .05), whereas D-NA and the acidic amino acid, L-Glu, exerted no such effect (table 2). Eadie-Scatchard analysis of ms L-NA transport in the presence of 0.05 mM L-Arg showed competitive inhibition of L-NA transport by L-Arg with a Ki value of 0.034 mM (fig. 5).
|
|
Effect of L-NA on Na+ absorption.
Na+ transport measured across the conjunctiva in
the absence and presence of L-NA is shown in table
3. Each tissue served as its own control
for the L-NA effect. L-NA at 1 mM significantly increased the ms
Na+ flux
(JNams) (P < .05) while
not affecting the sm Na+ flux
(JNasm). The net
Na+ flux
(JNanet) before and after adding
1 mM L-NA was 0.14 and 0.23 µEq/(cm2·hr),
respectively, leading to a net stimulation of 0.09 µEq/(cm2·hr) in Na+
absorption. Statistically,
JNanet and
Isc are not different (P > .05).
|
| |
Discussion |
|---|
|
|
|---|
The present study demonstrated that as was the case for L-Arg,
L-NA transport across the pigmented rabbit conjunctiva was carrier-mediated, probably via system
B0,+. Aside from the kinetic characteristics of
carrier-mediated transport (as shown in table 1 and fig. 3), L-NA
transport was reduced to 10% of its base-line value by basic amino
acids (e.g., L-Arg and L-Lys) and neutral amino
acids (e.g., L-Leu) but was not affected by
acidic amino acids (e.g., L-Glu) (table 2). L-Arg
transport across the conjunctiva exhibited very similar inhibitory
patterns (Hosoya et al., 1997
). It should, therefore, not be
surprising that L-Arg competitively inhibited L-NA transport with an
apparent Ki value of 0.034 mM (fig.
5), which is comparable in value to the
Km value of 0.07 mM for high affinity
L-Arg transport. As was the case for L-Arg transport (Hosoya et
al., 1997
), the stoichiometry between Na+
and L-NA was 1:1 (fig. 4). The sharing of a common transporter between
L-Arg and L-NAME was also observed in human hepatic plasma membrane
vesicles (Inoue et al., 1993
).
Nevertheless, there exist some subtle differences between L-NA and
L-Arg transport. First, whereas L-Arg transport is associated with both
a high and a low affinity process, with a corresponding Km value of 0.07 mM and 5.90 mM
(Hosoya et al., 1997
), L-NA transport is characterized by a
single kinetic process with a Km
value of 0.35 mM. In addition, the Ki
value for the inhibition of L-NA transport by L-Arg, 0.034 mM, is 10 times lower than the Km value of 0.35 mM for L-NA transport. Second, the pigmented rabbit conjunctiva has a 4 times lower capacity for transporting L-NA than L-Arg, as a comparison
between the Jmax of L-NA [290
pmol/(cm2·min)] and that of L-Arg in the low
affinity process [1248 pmol/(cm2·min)] would
reveal. Third, the
Isc (1.73 ± 0.01 µA/cm2) and
JNanet [0.09
µEq/(cm2·hr)] in the presence of 1 mM L-NA
are
30% smaller than those exhibited by L-Arg transport (Hosoya
et al., 1997
).
Although the basal NO level in the conjunctiva is negligible (Hosoya
et al., 1997
), NO is known to be elevated in the conjunctiva (Meijer et al., 1996
), retinal pigment epithelium (Goureau
et al., 1994
; Liversidge et al., 1994
) and uveal
tract (Mandai et al., 1994
) as a result of iNOS activity.
When L-NA was administered intraperitoneally (20 mg/rat) for
endotoxin-induced uveitis, iNOS activity was inhibited by 90% (Mandai
et al., 1994
). Similarly, intraperitoneally administered
L-NA (25-50 mg/kg) 1 hr before the induction of ischemic injury to the
retina of the rat prevented the increase in thickness of the inner
retinal and plexiform layers (Geyer et al., 1995
). Finally,
intravenously administered L-NA (200 mg/kg) completely blocked the
inflammatory response in the rabbit eye induced by a 2-min infrared
irradiation to the iris (Wang and Håkanson, 1995
). Collectively, these
findings suggest that L-NA may potentially be useful for alleviating
ocular inflammation. The stage is therefore set for exploring the
feasibility of delivering this and other NOS inhibitors topically at
perhaps a much lower dose than the intravenous and intraperitoneal
doses noted above.
It is conceivable that a L-NA concentration exceeding 1 µM may be
achieved in the vitreous fluid from a 10-µl topical dose of 1 mM L-NA
solution (containing 2.2 µg of drug). The necessary conditions are
(1) the entire bulbar conjunctiva of 3.3 cm2
(Hosoya and Lee, 1997
) is accessible to drug delivery, (2) the conjunctiva rather than the sclera is rate-limiting in drug transport, (3) drug clearance by the vasculature in the conjunctiva and sclera is
negligible, (4) the drug permeability as measured in vitro is comparable to that in vivo and (5) a minimum of 5 min in
residence time for the instilled dose is allowed. Given that the
maximal transconjunctival flux of L-NA is 290 pmol/(cm2·min) (fig. 3), the total amount of
drug in the vitreous will be 4.8 nmol [= flux (290 pmol/(cm2·min) × area (3.3 cm2) × residence time (5 min)]. Moreover,
because 99% of the vitreous body (4 ml) is water (Berman, 1991
), L-NA
concentration of
1.2 µM (0.26 µg/ml) can be achieved in the
vitreous. This concentration is close to the IC50
value of 1.4 µM for L-NA against purified rat brain NOS
(Pfeiffer et al., 1996
).
In conclusion, the findings in the present study are consistent with the possible involvement of system B0,+ in the transport of L-NA and perhaps other NOS inhibitors across the pigmented rabbit conjunctiva. Compared with L-Arg, L-NA shows less affinity (and a smaller maximal saturable flux) toward the conjunctival L-Arg transporter (B0,+). On the basis of the observed Papp and on the expectation that a delivery system targeting the bulbar conjunctiva will be available, it may be possible to deliver a therapeutic amount of L-NA to the uveal tract from the topical route. Further in vivo experimentation would be required to determine the extent to which such a desirable therapeutic goal can be achieved.
| |
Footnotes |
|---|
Accepted for publication December 3, 1997.
Received for publication July 21, 1997.
1 This work was supported in part by National Institutes of Health Grants EY10421 (V.H.L.L.) and HL38658 (K.-J.K.).
2 Present address: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku University, Aoba, Aramakiaza, Aoba-ku, Sendai 980-8578, Japan.
Send reprint requests to: Vincent H. L. Lee, Ph.D., Department of Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90033. E-mail: vincentl{at}hsc.usc.edu
| |
Abbreviations |
|---|
L-NA, NG-nitro-L-arginine;
ms, mucosal-to-serosal;
sm, serosal-to-mucosal;
Papp, apparent permeability
coefficient;
L-Arg, L-arginine;
L-Lys, L-lysine;
L-Leu, L-leucine;
L-Glu, L-glutamic acid;
NO, nitric oxide;
NOS, nitric oxide
synthase, iNOS, inducible nitric oxide synthase;
L-MMA, NG-monomethyl-L-arginine;
L-NAME, NG-nitro-L-arginine methyl ester;
D-NA, NG-nitro-D-arginine;
PD, potential difference;
Isc, short-circuit current;
Isc, increase in
short-circuit current;
TEER, transepithelial electrical resistance;
JNams, Na+ flux in the ms
direction;
JNasm, Na+ flux in the
sm direction;
JNanet, net Na+
flux.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. H. Levin, J. K. Kim, J. Hu, and A. S. Verkman Potential Difference Measurements of Ocular Surface Na+ Absorption Analyzed Using an Electrokinetic Model Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 306 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sloan, B. R. Grubb, and S. Mager Expression of the amino acid transporter ATB0+ in lung: possible role in luminal protein removal Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L39 - L49. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, V. H. L. Lee, K.-J. Kim, and R. Kannan Net Glutathione Secretion across Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1154 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueda, Y. Horibe, K.-J. Kim, and V. H. L. Lee Functional Characterization of Organic Cation Drug Transport in the Pigmented Rabbit Conjunctiva Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 870 - 876. [Abstract] [Full Text] |
||||
![]() |
J. L. Sloan and S. Mager Cloning and Functional Expression of a Human Na+ and Cl--dependent Neutral and Cationic Amino Acid Transporter B0+ J. Biol. Chem., August 20, 1999; 274(34): 23740 - 23745. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||